Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer

Journal of Epidemiology

Volumn 18, Issue 4, 2008, Pages 160-166

  Ogata, Tsuyoshi ^a   Yamazaki, Yoshinao ^b   Okabe, Nobuhiko ^c   Nakamura, Yosikazu ^d   Tashiro, Masato ^c   Nagata, Noriko ^e   Itamura, Shigeyuki ^c   Yasui, Yoshinori ^c   Nakashima, Kazutoshi ^c   Doi, Mikio ^e   Izumi, Youko ^e   Fujieda, Takashi ^e   Yamato, Shin'ichi ^e   Kawada, Yuichi ^e  

^a Chikusei Kyowa Health Center   (Japan)

^b Ibaraki Prefectural Institute of Public Health   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e Ibaraki Prefectural Office   (Japan)

Author keywords

H5N2; Human influenza; Influenza; Neutralization tests; Vaccination

Indexed keywords

VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL; ANIMAL DISEASE; ARTICLE; AVIAN INFLUENZA; CHICKEN; DISEASE TRANSMISSION; ENVIRONMENTAL MONITORING; EPIDEMIC; EQUIPMENT; HUMAN; HYGIENE; IMMUNOLOGY; INFLUENZA VIRUS A H5N2; JAPAN; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICS;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; ENVIRONMENTAL MONITORING; EQUIPMENT CONTAMINATION; HUMANS; HYGIENE; IMMUNITY, ACTIVE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; JAPAN; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 54449091776     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE2007446     Document Type: Article

References (20)

1. Ogata T, Nagata N. Avian influenza H5N2 occurred in Ibaraki. Infectious agents surveillance report (IASR) 2005;26:12-14 (in Japanese).
2. The team studying infectious process of highly pathogenic avian influenza. Infectious process of highly pathogenic avian influenza occurred in 2005. [cited 2008 Mar 3]. Available from: http://www.maff.go.jp/tori/kentoukai/report2005.pdf (in Japanese).
3. Okamatsu M, Saito T, Mase M, Tsukamoto K, Yamaguchi S. Characteristics of H5N2 influenza A viruses isolated from chickens in Japan. Avian Dis 2007 Mar;51 (1 suppl):474-5.
4. Lee CW, Senne DA, Suarez DL. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004;78:8372-81.
5. Okamatsu M, Saito T, Yamamoto Y, Mase M, Tsuduku S, Nakamura K, et al. Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005-2006. Vet Microbiol 2007;124:35-46.
6. World Health Organization. Avian influenza ("bird flu")-Fact sheet. [cited 2008 Mar 3]. Available from: http://www.who.int/ mediacentre/factsheets/avian_influenza/en/index.html.
7. World Health Organization. H5N1 avian influenza: timeline of major events. [cited 2008 Mar 3]. Available from: http://www.who.int/csr/ disease/avian_influenza/ai_timeline/en/index.html.
8. Myers KP, Setterquist SF, Capuano AW, Gray GC. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007;45:4-9.
9. Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, Chiappini R, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 2008;14:121-8.
10. World Health Organization. WHO manual on animal influenza diagnosis and surveillance. [cited 2008 Feb 20]. Available from: whqlibdoc.who.int/hq/ 2002/WHO_CDS_CSR_NCS_2002.5.pdf.
11. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004;10:2196-9.
12. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004;101:1356-61.
13. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, et al. Human infection with influenza H9N2. Lancet 1999;354:916-7.
14. Kawaoka Y, Naeve CW, Webster RG. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology 1984;139:303-16.
15. Horimoto T, Rivera E, Pearson J, Senne D, Krauss S, Kawaoka Y, et al. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology 1995;213:223-30.
16. Sandbulte MR, Jimenez GS, Boon ACM, Smith LR, Treanor JJ, Webby RJ. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007;4:e59. [cited 2008 Mar 3]. Available from: http://medicine.plosjournals.org/perlserv/?request=get-document&doi= 10.1371/journal.pmed.0040059.
17. Luk J, Gross P, Thompson WW. Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis 2001;33:1375-8.
18. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, et al. Current concepts: update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358:261-73.
19. Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, Itamura S, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007;196:1313-20.
20. World Health Organization. WHO case definitions for human influenza A (H5N1) virus. [cited 2008 Feb 20]. Available from: http://www.who.int/ csr/disease/avian_influenza/guidelines/case_definition2006_08_29/en/.